Literature DB >> 2263574

Improving follow-up after an abnormal Pap smear: a randomized controlled trial.

E D Paskett1, E White, W B Carter, J Chu.   

Abstract

Less than 60% of women diagnosed with cervical abnormalities on Pap smears return for proper surveillance and timely treatment. Previous tactics used to motivate these women to return have mainly relied on costly intensive recall efforts. Using a framework based on psychological value expectancy theory, a pamphlet was designed to motivate women with abnormal Pap smears to return for a repeat Pap smear. The effect of this pamphlet was tested in a randomized controlled trial. A total of 161 women with abnormal Pap smears were randomized and received either the pamphlet plus a notification letter or the letter only. The compliance rate was 64.2% in the intervention group and 51.3% in the comparison group (P = 0.10; two-tailed). In addition, subgroups of women who do not practice health-related behaviors were identified as groups where more intensive interventions may be needed. These results have implications for future strategies used to recall women with abnormal Pap smears.

Entities:  

Mesh:

Year:  1990        PMID: 2263574     DOI: 10.1016/0091-7435(90)90060-w

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  16 in total

Review 1.  Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour.

Authors:  F Fylan
Journal:  Br J Gen Pract       Date:  1998-08       Impact factor: 5.386

2.  Inadequate follow-up for abnormal Pap smears in an urban population.

Authors:  Neeraja B Peterson; Jini Han; Karen M Freund
Journal:  J Natl Med Assoc       Date:  2003-09       Impact factor: 1.798

Review 3.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

4.  The impact of mailing psychoeducational materials to women with abnormal mammograms.

Authors:  C Lerman; E Ross; A Boyce; P M Gorchov; R McLaughlin; B Rimer; P Engstrom
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

5.  The costs and effects of cervical and breast cancer screening in a public hospital emergency room. The Cancer Control Center of Harlem.

Authors:  J Mandelblatt; H Freeman; D Winczewski; K Cagney; S Williams; R Trowers; J Tang; K Gold; T H Lin; J Kerner
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

6.  Healthcare use after screening for lung cancer.

Authors:  Margaret M Byrne; Tulay Koru-Sengul; Wei Zhao; Joel L Weissfeld; Mark S Roberts
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

Review 7.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

Review 8.  Adherence and psychological adjustment among women at high risk for breast cancer.

Authors:  C Lerman; M Schwartz
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

9.  Tracking abnormal cervical cancer screening: evaluation of an EMR-based intervention.

Authors:  Elizabeth A Dupuis; Hilary F White; Daniel Newman; Jerome E Sobieraj; Manjusha Gokhale; Karen M Freund
Journal:  J Gen Intern Med       Date:  2010-03-04       Impact factor: 5.128

10.  Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population.

Authors:  Karin Nelson; Ann M Geiger; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.